New generation of herbicide-tolerant crops face regulatory delays

d d a
Credit: Flickr/agrilifetoday

The following is an editorial summary of a longer story.

Monsanto and Dow Chemical face delays in selling biotech crops engineered to survive older weedkillers after the the U.S. Department of Agriculture announced increased scrutiny of the genetically modified plants. The new crops will be evaluated in separate environmental impact statements — a longer and more intensive review process than the environmental assessments previously used by the USDA to evaluate biotech crops.

The GLP has written previously about the dangers of over-regulation for biotech crops and foods with regards to the AquAdvantage GM salmon and the so-called “Monsanto Protection Act.”

You can read the USDA’s statement on the new regulatory approach here.

View the full story here: Monsanto, Dow Crops Face Delays as U.S. Increases Scrutiny


Additional Resources:


Outbreak Daily Digest
Biotech Facts & Fallacies
Talking Biotech
Genetics Unzipped
Infographic: What are mRNA COVID-19 vaccines and how do they work?

Infographic: What are mRNA COVID-19 vaccines and how do they work?

As of 1 December 2020, thirteen vaccines have reached the final stage of testing: where they are being given to ...

Environmental Working Group: EWG challenges safety of GMOs, food pesticide residues

Known by some as the "Environmental Worrying Group," EWG lobbies ...
m hansen

Michael Hansen: Architect of Consumers Union ongoing anti-GMO campaign

Michael K. Hansen (born 1956) is thought by critics to be ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend